Eton Pharmaceuticals Changes Auditors
Ticker: ETON · Form: 8-K · Filed: Jun 20, 2025 · CIK: 1710340
Sentiment: neutral
Topics: auditor-change, administrative
TL;DR
Eton Pharma swapped accountants, bringing in BDO USA, P.A. after parting ways with CohnReznick LLP.
AI Summary
Eton Pharmaceuticals, Inc. announced on June 13, 2025, a change in its certifying accountant. The company has dismissed its previous independent registered public accounting firm, CohnReznick LLP, effective June 13, 2025. Eton Pharmaceuticals has appointed BDO USA, P.A. as its new independent registered public accounting firm.
Why It Matters
A change in auditors can sometimes signal underlying issues or a desire for a fresh perspective on financial reporting, which investors should monitor.
Risk Assessment
Risk Level: low — This filing pertains to a routine administrative change in the company's auditing firm and does not indicate any immediate financial distress or operational issues.
Key Players & Entities
- Eton Pharmaceuticals, Inc. (company) — Registrant
- CohnReznick LLP (company) — Previous certifying accountant
- BDO USA, P.A. (company) — New certifying accountant
- June 13, 2025 (date) — Effective date of accountant change
FAQ
When was the change in Eton Pharmaceuticals' certifying accountant effective?
The change was effective as of June 13, 2025.
Who was Eton Pharmaceuticals' previous independent registered public accounting firm?
Eton Pharmaceuticals' previous independent registered public accounting firm was CohnReznick LLP.
Who has Eton Pharmaceuticals appointed as its new independent registered public accounting firm?
Eton Pharmaceuticals has appointed BDO USA, P.A. as its new independent registered public accounting firm.
Did the previous accountant report any disagreements with Eton Pharmaceuticals?
The filing states that there were no disagreements or reportable events between Eton Pharmaceuticals and CohnReznick LLP.
What is the address of Eton Pharmaceuticals' principal executive offices?
The address of Eton Pharmaceuticals' principal executive offices is 21925 W. Field Parkway, Suite 235, Deer Park, Illinois 60010-7278.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding Eton Pharmaceuticals, Inc. (ETON).